IRulya Reports Third-Quarter 2026 Net Loss of $27.7 Million, Cash of $105.2 Million

IRulya reported a net loss of $27.7 million for the third quarter of 2026, compared with $13.4 million a year earlier. The company ended September with $105.2 million in cash, cash equivalents and investments, which it expects to fund operations through the end of 2028. Its Phase 2 trial in bronchi…